Sana Biotechnology Inc (SANA)
10.44
+0.66
(+6.75%)
USD |
NASDAQ |
May 03, 16:00
10.44
0.00 (0.00%)
After-Hours: 18:58
Sana Biotechnology Total Liabilities (Quarterly): 277.79M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 277.79M |
| September 30, 2023 | 265.59M |
| June 30, 2023 | 352.12M |
| March 31, 2023 | 318.67M |
| December 31, 2022 | 323.40M |
| September 30, 2022 | 332.08M |
| June 30, 2022 | 331.58M |
| March 31, 2022 | 345.96M |
| Date | Value |
|---|---|
| December 31, 2021 | 400.90M |
| September 30, 2021 | 402.67M |
| June 30, 2021 | 353.94M |
| March 31, 2021 | 422.48M |
| December 31, 2020 | 1.151B |
| September 30, 2020 | 1.079B |
| December 31, 2019 | 557.73M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
265.59M
Minimum
Sep 2023
1.151B
Maximum
Dec 2020
461.02M
Average
352.12M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Rocket Pharmaceuticals Inc | 73.77M |
| Solid Biosciences Inc | 38.46M |
| Dyne Therapeutics Inc | 73.79M |
| Taysha Gene Therapies Inc | 97.79M |
| Tenaya Therapeutics Inc | 31.09M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 565.30M |
| Shareholders Equity (Quarterly) | 287.51M |